These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1556 related articles for article (PubMed ID: 33648563)

  • 21. The CHARTER-Ireland trial: can nebulised heparin reduce acute lung injury in patients with SARS-CoV-2 requiring advanced respiratory support in Ireland: a study protocol and statistical analysis plan for a randomised control trial.
    Sheehan JR; Calpin P; Kernan M; Kelly C; Casey S; Murphy D; Alvarez-Iglesias A; Giacomini C; Cody C; Curley G; McGeary S; Hanley C; McNicholas B; van Haren F; Laffey JG; Cosgrave D
    Trials; 2022 Sep; 23(1):774. PubMed ID: 36104785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Personalized mechanical ventilation guided by ultrasound in patients with acute respiratory distress syndrome (PEGASUS): study protocol for an international randomized clinical trial.
    Sinnige JS; Smit MR; Ghose A; de Grooth HJ; Itenov TS; Ischaki E; Laffey J; Paulus F; Póvoa P; Pierrakos C; Pisani L; Roca O; Schultz MJ; Szuldrzynski K; Tuinman PR; Zimatore C; Bos LDJ;
    Trials; 2024 May; 25(1):308. PubMed ID: 38715118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Intravenous Interferon β-1a on Death and Days Free From Mechanical Ventilation Among Patients With Moderate to Severe Acute Respiratory Distress Syndrome: A Randomized Clinical Trial.
    Ranieri VM; Pettilä V; Karvonen MK; Jalkanen J; Nightingale P; Brealey D; Mancebo J; Ferrer R; Mercat A; Patroniti N; Quintel M; Vincent JL; Okkonen M; Meziani F; Bellani G; MacCallum N; Creteur J; Kluge S; Artigas-Raventos A; Maksimow M; Piippo I; Elima K; Jalkanen S; Jalkanen M; Bellingan G;
    JAMA; 2020 Feb; 323(8):725-733. PubMed ID: 32065831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Phase II Safety and Efficacy Study on Prognosis of Moderate Pneumonia in Coronavirus Disease 2019 Patients With Regular Intravenous Immunoglobulin Therapy.
    Raman RS; Bhagwan Barge V; Anil Kumar D; Dandu H; Rakesh Kartha R; Bafna V; Aravinda VT; Raghuram TC
    J Infect Dis; 2021 May; 223(9):1538-1543. PubMed ID: 33585890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome.
    Gates S; Perkins GD; Lamb SE; Kelly C; Thickett DR; Young JD; McAuley DF; Snaith C; McCabe C; Hulme CT; Gao Smith F
    Health Technol Assess; 2013 Sep; 17(38):v-vi, 1-87. PubMed ID: 24028755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global Impact of Coronavirus Disease 2019 Infection Requiring Admission to the ICU: A Systematic Review and Meta-analysis.
    Tan E; Song J; Deane AM; Plummer MP
    Chest; 2021 Feb; 159(2):524-536. PubMed ID: 33069725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology and Outcomes of Acute Kidney Injury in COVID-19 Patients with Acute Respiratory Distress Syndrome: A Multicenter Retrospective Study.
    Wang F; Ran L; Qian C; Hua J; Luo Z; Ding M; Zhang X; Guo W; Gao S; Gao W; Li C; Liu Z; Li Q; Ronco C
    Blood Purif; 2021; 50(4-5):499-505. PubMed ID: 33291098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serious complications in COVID-19 ARDS cases: pneumothorax, pneumomediastinum, subcutaneous emphysema and haemothorax.
    Guven BB; Erturk T; Kompe Ö; Ersoy A
    Epidemiol Infect; 2021 Jun; 149():e137. PubMed ID: 34099076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial.
    Gharebaghi N; Nejadrahim R; Mousavi SJ; Sadat-Ebrahimi SR; Hajizadeh R
    BMC Infect Dis; 2020 Oct; 20(1):786. PubMed ID: 33087047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: study protocol for a randomized, placebo-controlled, and multicenter trial.
    Boesing M; Abig K; Brändle M; Brutsche M; Burri E; Frye BC; Giezendanner S; Grutters JC; Haas P; Heisler J; Jaun F; Leuppi-Taegtmeyer AB; Lüthi-Corridori G; Müller-Quernheim J; Nüesch R; Pohl W; Rassouli F; Leuppi JD
    Trials; 2022 Sep; 23(1):790. PubMed ID: 36127739
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pilot study on intravenous N-Acetylcysteine treatment in patients with mild-to-moderate COVID19-associated acute respiratory distress syndrome.
    Taher A; Lashgari M; Sedighi L; Rahimi-Bashar F; Poorolajal J; Mehrpooya M
    Pharmacol Rep; 2021 Dec; 73(6):1650-1659. PubMed ID: 34114174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study.
    COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators
    Intensive Care Med; 2021 Jan; 47(1):60-73. PubMed ID: 33211135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
    Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G
    Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of acute respiratory distress syndrome in COVID-19 patients compared to the general population: a systematic review and meta-analysis.
    Dmytriw AA; Chibbar R; Chen PPY; Traynor MD; Kim DW; Bruno FP; Cheung CC; Pareek A; Chou ACC; Graham J; Dibas M; Paranjape G; Reierson NL; Kamrowski S; Rozowsky J; Barrett A; Schmidt M; Shahani D; Cowie K; Davis AR; Abdelmegeed M; Touchette JC; Kallmes KM; Pederson JM; Keesari PR
    Expert Rev Respir Med; 2021 Oct; 15(10):1347-1354. PubMed ID: 33882768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak.
    Wang Z; Wang Z
    BMC Infect Dis; 2021 Jan; 21(1):113. PubMed ID: 33494706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nebulised heparin for patients with or at risk of acute respiratory distress syndrome: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial.
    Dixon B; Smith RJ; Campbell DJ; Moran JL; Doig GS; Rechnitzer T; MacIsaac CM; Simpson N; van Haren FMP; Ghosh AN; Gupta S; Broadfield EJC; Crozier TME; French C; Santamaria JD;
    Lancet Respir Med; 2021 Apr; 9(4):360-372. PubMed ID: 33493448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the efficacy of equivalent doses of dexamethasone, methylprednisolone, and hydrocortisone for treatment of COVID-19-related acute respiratory distress syndrome: a prospective three-arm randomized clinical trial.
    Taher A; Lashkari M; Keramat F; Hashemi SH; Sedighi L; Poorolajal J; Mehrpooya M
    Wien Med Wochenschr; 2023 Apr; 173(5-6):140-151. PubMed ID: 36624180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of EIT-guided PEEP titration on prognosis of patients with moderate to severe ARDS: study protocol for a multicenter randomized controlled trial.
    Yuan X; Zhang R; Wang Y; Chen D; Chao Y; Xu J; Guo L; Liu A; Xie J; Pan C; Yang Y; Qiu H; Liu L
    Trials; 2023 Apr; 24(1):266. PubMed ID: 37041561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultra-low tidal volume ventilation for COVID-19-related ARDS in France (VT4COVID): a multicentre, open-label, parallel-group, randomised trial.
    Richard JC; Terzi N; Yonis H; Chorfa F; Wallet F; Dupuis C; Argaud L; Delannoy B; Thiery G; Pommier C; Abraham P; Muller M; Sigaud F; Rigault G; Joffredo E; Mezidi M; Souweine B; Baboi L; Serrier H; Rabilloud M; Bitker L;
    Lancet Respir Med; 2023 Nov; 11(11):991-1002. PubMed ID: 37453445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the efficacy and safety of FP-1201-lyo (intravenously administered recombinant human interferon beta-1a) and placebo in the treatment of patients with moderate or severe acute respiratory distress syndrome: study protocol for a randomized controlled trial.
    Bellingan G; Brealey D; Mancebo J; Mercat A; Patroniti N; Pettilä V; Quintel M; Vincent JL; Maksimow M; Jalkanen M; Piippo I; Ranieri VM
    Trials; 2017 Nov; 18(1):536. PubMed ID: 29132404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 78.